naringenin has been researched along with Bilateral Wilms Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Chen, P; Li, H; Wang, X | 1 |
1 other study(ies) available for naringenin and Bilateral Wilms Tumor
Article | Year |
---|---|
The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling.
Topics: Animals; Antineoplastic Agents; Biological Products; Cell Proliferation; Cell Survival; Child; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavanones; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; NF-kappa B; Signal Transduction; Structure-Activity Relationship; Toll-Like Receptor 4; Tumor Cells, Cultured; Wilms Tumor | 2021 |